Vincristine

Symptoms / Indications

• Acute lymphoblastic leukemia (ALL)
• Hodgkin’s lymphoma
• Non-Hodgkin’s lymphoma
• Neuroblastoma
• Wilms’ tumor
• Rhabdomyosarcoma
• Small cell lung cancer (in combination therapy)
• Other malignancies treated with combination chemotherapy

Product Overview

Vincristine Injection contains Vincristine Sulfate, a chemotherapy medication belonging to the vinca alkaloid class of anticancer agents. It is commonly used as part of combination chemotherapy protocols to treat various types of cancers, including leukemia, lymphoma, and solid tumors. Vincristine works by interfering with the growth and division of cancer cells, helping to slow or stop tumor progression.

This injectable formulation is administered by qualified healthcare professionals in controlled clinical environments such as hospitals and oncology treatment centers. Vincristine is widely recognized in oncology treatment regimens due to its role in multi-drug chemotherapy protocols. Manufactured under strict pharmaceutical quality standards, this product is suitable for hospitals, oncology clinics, and pharmaceutical distributors seeking reliable oncology formulations for domestic and international markets.

Therapeutic Category

Anticancer / Antineoplastic Agent (Vinca Alkaloid)

Dosage Form

Injection

Mechanism of Action

Vincristine belongs to the vinca alkaloid class of anticancer drugs. It works by inhibiting microtubule formation within cancer cells, which disrupts the mitotic spindle required for cell division. By preventing proper chromosome separation during mitosis, Vincristine effectively stops the proliferation of rapidly dividing cancer cells, leading to inhibition of tumor growth.

Dosage & Administration

Vincristine Injection must be administered by a qualified healthcare professional experienced in chemotherapy treatment. The dosage is determined based on the patient’s medical condition, body surface area, and treatment protocol. It is typically given via intravenous administration under strict clinical supervision. Self-administration or dosage adjustments without medical guidance should be avoided.

Side Effects

• Nausea and vomiting
• Peripheral neuropathy (nerve-related symptoms)
• Hair loss (alopecia)
• Constipation

Precautions & Warnings

Vincristine should only be administered under the supervision of experienced oncology professionals. Patients with liver impairment require careful monitoring and possible dose adjustments. Close monitoring is recommended due to potential neurotoxic effects. Avoid self-medication and ensure the drug is not used outside prescribed chemotherapy protocols.

Drug Interactions

Vincristine may interact with certain antifungal medications, antibiotics, and other chemotherapy agents that affect liver enzyme metabolism. Concomitant use with drugs that affect nerve function may increase the risk of neurotoxicity. Medical supervision is required when used alongside other medications.

Pregnancy & Breastfeeding

Pregnancy: Consult doctor before use
Breastfeeding: Consult doctor before use

Storage

Store in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Shelf Life

24 months

Quality & Compliance

This product is manufactured in a WHO-GMP compliant facility under strict pharmaceutical quality standards. Each batch undergoes rigorous testing for sterility, potency, and stability. The formulation is suitable for hospitals, oncology treatment centers, and international pharmaceutical markets with appropriate export documentation.

Business Opportunity

Allotab Healthcare is a leading pharmaceutical manufacturer and exporter operating from a WHO-GMP and EU-GMP certified facility in India, ensuring the highest standards of quality and compliance. We offer a wide range of pharmaceutical formulations including tablets, capsules, injections, ointments, oral liquids, and advanced molecules, catering to diverse therapeutic segments. Our portfolio also includes a comprehensive range of oncology products, supporting global healthcare needs. With strong manufacturing capabilities, regulatory expertise, and reliable supply, Allotab Healthcare serves distributors, hospitals, and healthcare organizations across international markets.

Bulk supply of Vincristine Injection is available for oncology hospitals, distributors, and global healthcare markets. Export support, regulatory documentation, and customized packaging options can be provided to meet international requirements.

Disclaimer

This information is for informational purposes only. Use under medical supervision.